•
Jun 30, 2024

iTeos Therapeutics Q2 2024 Earnings Report

Total Revenue
$35M
EPS
-$0.18
Previous year: -$0.96
-81.3%
Gross Profit
$34.7M
Cash and Equivalents
$571M
Previous year: $216M
+164.2%
Free Cash Flow
-$34.4M
Previous year: -$30.2M
+13.6%
Total Assets
$752M
Previous year: $704M
+6.8%

iTeos Therapeutics

iTeos Therapeutics